Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tandospirone and Amlodipine in Hypertension and Anxiety
NCT03667677Phase 4Unknown
- Sponsor
- Chongqing Medical University
- Start
- Feb 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tandospirone in hypertension (HTN) and anxiety disorder, sponsored by Chongqing Medical University. Status: unknown.
02
Drugs
tandospirone
03
Conditions
hypertension (HTN)anxiety disorder
Beyond the preview
Go deeper on NCT03667677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03667677.